IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, Via R. Galeazzi 4, I-20161 Milano, Italy.
IRCCS Istituto Ortopedico Galeazzi, Cell and Tissue Engineering Laboratory, Via R. Galeazzi 4, I-20161 Milano, Italy.
Cells. 2020 May 9;9(5):1180. doi: 10.3390/cells9051180.
Extracellular vesicles (EVs) showed therapeutic properties in several applications, many in regenerative medicine. A clear example is in the treatment of osteoarthritis (OA), where adipose-derived mesenchymal stem cells (ASCs)-EVs were able to promote regeneration and reduce inflammation in both synovia and cartilage. A still obscure issue is the effective ability of EVs to be internalized by target cells, rather than simply bound to the extracellular matrix (ECM) or plasma membrane, since the current detection or imaging technologies cannot fully decipher it due to technical limitations. In the present study, human articular chondrocytes (ACHs) and fibroblast-like synoviocytes (FLSs) isolated from the same OA patients were cocultured in 2D as well as in 3D conditions with fluorescently labeled ASC-EVs, and analyzed by flow cytometry or confocal microscopy, respectively. In contrast with conventional 2D, in 3D cultures, confocal microscopy allowed a clear detection of the tridimensional morphology of the cells and thus an accurate discrimination of EV interaction with the external and/or internal cell environment. In both 2D and 3D conditions, FLSs were more efficient in interacting with ASC-EVs and 3D imaging demonstrated a faster uptake process. The removal of the hyaluronic acid component from the ECM of both cell types reduced their interaction with ASC-EVs only in the 2D system, showing that 2D and 3D conditions can yield different outcomes when investigating events where ECM plays a key role. These results indicate that studying EVs binding and uptake both in 2D and 3D guarantees a more precise and complementary characterization of the molecular mechanisms involved in the process. The implementation of this strategy can become a valuable tool not only for basic research, but also for release assays and potency prediction for clinical EV batches.
细胞外囊泡 (EVs) 在许多应用中表现出治疗特性,在再生医学中尤为明显。一个明显的例子是在骨关节炎 (OA) 的治疗中,脂肪间充质干细胞 (ASCs)-EVs 能够促进滑膜和软骨的再生和减少炎症。一个仍然模糊的问题是 EVs 被靶细胞内化的有效能力,而不是简单地结合到细胞外基质 (ECM) 或质膜上,因为由于技术限制,当前的检测或成像技术不能完全破译它。在本研究中,从同一 OA 患者分离的人关节软骨细胞 (ACHs) 和成纤维样滑膜细胞 (FLSs) 在 2D 和 3D 条件下与荧光标记的 ASC-EVs 共培养,并分别通过流式细胞术或共聚焦显微镜进行分析。与传统的 2D 相比,在 3D 培养中,共聚焦显微镜允许清楚地检测细胞的三维形态,从而可以准确区分 EV 与外部和/或内部细胞环境的相互作用。在 2D 和 3D 条件下,FLSs 与 ASC-EVs 的相互作用效率更高,并且 3D 成像显示出更快的摄取过程。从两种细胞类型的 ECM 中去除透明质酸成分仅在 2D 系统中降低了它们与 ASC-EVs 的相互作用,表明 2D 和 3D 条件在研究 ECM 起关键作用的事件时可能产生不同的结果。这些结果表明,在 2D 和 3D 中研究 EVs 的结合和摄取可以更精确和互补地描述参与该过程的分子机制。该策略的实施不仅可以成为基础研究的有力工具,而且可以成为临床 EV 批次的释放测定和效力预测的有用工具。